![](/img/cover-not-exists.png)
H01*A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial:
Daniele, G., Morabito, A., Favaretto, A., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Valmadre, G., Costanzo, R., Manzo, A., Bonanno, L., Piazza, E., Maione, P., MVolume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv343.01
Date:
October, 2015
File:
PDF, 39 KB
english, 2015